Dr. Eva Surmacz is the Director of Obesity and Cancer Program at SHRO and Professor in Biology (Adjunct) at CST. Her research focuses on molecular links between cancer development and metabolic dysregulation associated with obesity
and diabetes. In particular, Dr. Surmacz's pioneering work on fat-derived hormones leptin and adiponectin underpinned the mechanisms of obesity-associated pro-neoplastic events in different human cancers. Her further advanced the
development of therapeutic compounds targeting these detrimental pathways. Dr. Surmacz authored over 95 peer-reviewed publications and several book chapters. Her work has been supported by the NIH, Department of Defense,
Pennsylvania Department of Health, pharmaceutical industry, and private organizations. Dr. Surmacz serves on editorial boards of 5 professional journals and has journalistic experience in popularizing biomedical discoveries. She
also co-founded and served as VP Research in 2 start-up biotech companies. Until present, Dr. Surmacz has mentored 30 full-time graduate students, residents and post-doctoral fellows, including several international researchers.
In the Bioinnovation program, Dr. Surmacz teaches courses on novel bioconcepts and biomodels, discovery and commercialization of biomarkers and biotargets, milestones in drug development, principles of pharmacovigilance, and
scientific communication. Dr. Surmacz serves as PSM Bioinnovation Academic Director.